Wits Commercial Enterprise
Share:
Overview of innovation

Non-toxic biodegradable wound dressing that releases drugs in response to inflammation and mimics skin cells. This accelerates the healing process and results in minimal scar formation, allowing wounds to achieve optimal healing.

Despite the existence of sophisticated materials used in preparing wound dressings, existing dressings do not respond to stimuli such as inflammation. In addition, the need for multiple dressing changes can be painful and has the potential to cause damage to delicate healing tissue affecting complete and timely wound healing.

Wits researchers have developed a wound dressing that contains a bioactive polymer that responds to inflammation and mimics the native skin cells and biological processes. The improved wound dressing accelerates wound healing and reduces the need for dressing changes. 

Type of Intellectual Property protection
Patent
Innovation Opportunity Type
Collaboration
Funding
Investment
Licensing
Partnership
Industry
Human health and social work activities
Therapeutics
Pharmaceuticals and Biopharmaceuticals
Medical Devices
Health Technologies
Technology Readiness Level
TRL 4 – Experimental prototype developed
Brochures, business plans, prospectus or other documents